Biotronics AI
Founded in 2024, Biotronics AI aims to revolutionize life sciences by enhancing medical, forensic, and related fields with advanced AI and quantum computing. Their core mission is to perfect diagnostic and treatment processes, tackling issues like misdiagnosis that affects millions annually. Biotronics integrates quantum computing and AI into molecular biology and life sciences, offering a groundbreaking advancement. Their product suite includes Bio-Q, a quantum algorithm for drug discovery and molecular design, ForenSight, an AI tool for forensic genetics analysis, and MediSight, an AI model for medical image analysis and tumor growth simulation. The company's vision is to create technological solutions at the intersection of health, justice, and sustainability, impacting human life on a global scale. While Bio-Q and MediSight are for institutional use in academic/medical settings, ForenSight is a free, open-source tool for forensic organizations.
Biotronics AI
Founded in 2024, Biotronics AI aims to revolutionize life sciences by enhancing medical, forensic, and related fields with advanced AI and quantum computing. Their core mission is to perfect diagnostic and treatment processes, tackling issues like misdiagnosis that affects millions annually. Biotronics integrates quantum computing and AI into molecular biology and life sciences, offering a groundbreaking advancement. Their product suite includes Bio-Q, a quantum algorithm for drug discovery and molecular design, ForenSight, an AI tool for forensic genetics analysis, and MediSight, an AI model for medical image analysis and tumor growth simulation. The company's vision is to create technological solutions at the intersection of health, justice, and sustainability, impacting human life on a global scale. While Bio-Q and MediSight are for institutional use in academic/medical settings, ForenSight is a free, open-source tool for forensic organizations.